STUDY SEARCH RESULTS

1 study found for your search request:  4464-001

Study of MK-4464 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced/...
Condition: advanced/metastatic solid tumors, neoplasms
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05514444
Status: Active, not recruiting




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site